Silencing PROK2 Inhibits Invasion of Human Cervical Cancer Cells by Targeting MMP15 Expression

Cervical cancer is the second most frequent type of gynecologic cancer worldwide. Prokineticin 2 (PROK2) is reported to be involved in tumor progression in some malignant tumors. However, the role of PROK2 in the development of cervical cancer remains unknown. Our results indicate that PROK2 is over...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Min-Hua, Wu, Pei-Ru, Hsieh, Yi-Hsien, Lin, Chia-Liang, Liu, Chung-Jung, Ying, Tsung-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504693/
https://www.ncbi.nlm.nih.gov/pubmed/32887509
http://dx.doi.org/10.3390/ijms21176391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504693/
https://www.ncbi.nlm.nih.gov/pubmed/32887509
http://dx.doi.org/10.3390/ijms21176391

Ejemplares similares